Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer

Scagliotti, Giorgio V.
Last
2017-01-01

2017
104
45
51
www.elsevier.com/locate/lungcan
Advanced non-small cell lung cancer; Elderly; Meta-analysis; Overall survival; Pemetrexed; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Disease-Free Survival; Humans; Lung Neoplasms; Pemetrexed; Platinum; Retrospective Studies; Treatment Outcome; Oncology; Pulmonary and Respiratory Medicine; Cancer Research
Paz-Ares, Luis G.*; Zimmermann, Annamaria; Ciuleanu, Tudor; Bunn, Paul A.; Antonio, Belen San; Denne, Jonathan; Iturria, Nancy; John, William; Scagliotti, Giorgio V.
File in questo prodotto:
File Dimensione Formato  
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 627.29 kB
Formato Adobe PDF
627.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1680279
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact